CardioVascular BioTherapeutics (fka CVBT)

[BirnamWood]

Thanks for posting, Donkey. Walhall does a wonderful job reminding us to keep our expectations in check as it’s all too easy to get carried away in the afterglow of ousting Dan Montano. Shareholders could have benefited from his forensic skills when Dan Montano was driving the company to ruination. It’s a shame Walhall wasn’t on his case. Perhaps Walhall can share his views on the ethics and likely consequences of our former Chairman’s activities as they seem potentially more harmful to us than anything of which the current Chairman may stand accused?